European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-06-18

Cell and gene therapy based approaches for treatment of Parkinson's disease: from models to clinics

Obiettivo

Parkinson s disease is one of the common causes of disability in the aging population, representing a major health problem for the affected individuals and a socioeconomic burden to the society. In the present proposal, the applicant puts forward an ambitious but feasible program to tackle a number of significant issues that remain unsolved in the field. He combines his strong track record in animal models of Parkinson s disease and novel cell and gene therapy-based therapeutic strategies with powerful bio-imaging techniques in order to make bold steps towards translation of new and better treatments to patients suffering from this illness. He does so in a manner that combines, on one hand, the strength of clearly-defined hypotheses and well-established tools for results towards clinical translation, with high-risk high-reward projects that hold the potential to yield ground-breaking discoveries in implementation of novel imaging techniques, on the other.

Invito a presentare proposte

ERC-2009-StG
Vedi altri progetti per questo bando

Meccanismo di finanziamento

ERC-SG - ERC Starting Grant

Istituzione ospitante

MAX IV Laboratory, Lund University
Contributo UE
€ 1 508 940,00
Indirizzo
Paradisgatan 5c
22100 LUND
Svezia

Mostra sulla mappa

Regione
Södra Sverige Sydsverige Skåne län
Tipo di attività
Higher or Secondary Education Establishments
Ricercatore principale
Deniz Kirik (Prof.)
Contatto amministrativo
Deniz Kirik (Prof.)
Collegamenti
Costo totale
Nessun dato

Beneficiari (1)